277 related articles for article (PubMed ID: 21573151)
1. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.
Wohlfart S; Khalansky AS; Gelperina S; Maksimenko O; Bernreuther C; Glatzel M; Kreuter J
PLoS One; 2011 May; 6(5):e19121. PubMed ID: 21573151
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development.
Maksimenko O; Malinovskaya J; Shipulo E; Osipova N; Razzhivina V; Arantseva D; Yarovaya O; Mostovaya U; Khalansky A; Fedoseeva V; Alekseeva A; Vanchugova L; Gorshkova M; Kovalenko E; Balabanyan V; Melnikov P; Baklaushev V; Chekhonin V; Kreuter J; Gelperina S
Int J Pharm; 2019 Dec; 572():118733. PubMed ID: 31689481
[TBL] [Abstract][Full Text] [Related]
3. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells.
Malinovskaya Y; Melnikov P; Baklaushev V; Gabashvili A; Osipova N; Mantrov S; Ermolenko Y; Maksimenko O; Gorshkova M; Balabanyan V; Kreuter J; Gelperina S
Int J Pharm; 2017 May; 524(1-2):77-90. PubMed ID: 28359811
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C
Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
6. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
7. Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma.
Pereverzeva E; Treschalin I; Treschalin M; Arantseva D; Ermolenko Y; Kumskova N; Maksimenko O; Balabanyan V; Kreuter J; Gelperina S
Int J Pharm; 2019 Jan; 554():161-178. PubMed ID: 30414476
[TBL] [Abstract][Full Text] [Related]
8. Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles.
Wohlfart S; Khalansky AS; Bernreuther C; Michaelis M; Cinatl J; Glatzel M; Kreuter J
Int J Pharm; 2011 Aug; 415(1-2):244-51. PubMed ID: 21641983
[TBL] [Abstract][Full Text] [Related]
9. Use of nanoparticles for cerebral cancer.
Kreuter J; Gelperina S
Tumori; 2008; 94(2):271-7. PubMed ID: 18564616
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of cancer-targeting doxorubicin-loaded PLGA nanoparticles arrests glioblastoma growth.
Chung K; Ullah I; Kim N; Lim J; Shin J; Lee SC; Jeon S; Kim SH; Kumar P; Lee SK
J Drug Target; 2020 Jul; 28(6):617-626. PubMed ID: 31852284
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
[TBL] [Abstract][Full Text] [Related]
13. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity.
Yan F; Zhang C; Zheng Y; Mei L; Tang L; Song C; Sun H; Huang L
Nanomedicine; 2010 Feb; 6(1):170-8. PubMed ID: 19447200
[TBL] [Abstract][Full Text] [Related]
14. Combination nanochemotherapy of brain tumor using polymeric nanoparticles loaded with doxorubicin and paclitaxel: An in vitro and in vivo study.
Malekpour MR; Hosseindoost S; Madani F; Kamali M; Khosravani M; Adabi M
Eur J Pharm Biopharm; 2023 Dec; 193():175-186. PubMed ID: 37926270
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
Mosafer J; Teymouri M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
[TBL] [Abstract][Full Text] [Related]
17. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
[TBL] [Abstract][Full Text] [Related]
19. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
[TBL] [Abstract][Full Text] [Related]
20. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]